Reagents and peripherals supplies to be order for genetic analysis products for testing such as: miseqdx - cystic fibrosis clinical sequencing assay 6 (run) and miseqdx - cystic fibrosis 139 variant…
Ended Awarded
- Contract number
- HT001417F0323
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $150,000
Award facts
- Contract value 100% obligated
- $150,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award to Illumina, Inc. is for the provision of reagents and supplies to support genetic analysis products such as the MiSeqDx Cystic Fibrosis Clinical Sequencing Assay, the MiSeqDx Cystic Fibrosis 139 Variant Assay, and the MiSeqDx Cystic Fibrosis Variant Assay, as well as MiSeq Reagent Kits. The contract is a Blanket Purchase Agreement (BPA) Call, with a firm fixed price pricing structure, awarded by the Defense Health Agency. The potential value of the award is $150,000.00, and it does not have a set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has provided similar products and services to federal agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs in the past.
Description
Reagents and peripherals supplies to be order for genetic analysis products for testing such as: miseqdx - cystic fibrosis clinical sequencing assay 6 (run) and miseqdx - cystic fibrosis 139 variant assay (20 run) and miseqdx - cystic fibrosis variant assay (2 run) and miseq reagent kit V2 (50 cycle) etc.
Quick answers
Who was awarded contract HT001417F0323?
HT001417F0323 was awarded to Illumina, Inc. by Defense Health Agency (Department of Defense) on September 22, 2017.
How much is contract HT001417F0323 worth?
The government has obligated $150,000 on HT001417F0323.
Is contract HT001417F0323 an order under another contract?
Yes. HT001417F0323 is a BPA call under HT001417A0025, a blanket purchase agreement.
Was contract HT001417F0323 competed?
The extent of competition for HT001417F0323 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award